Management of Dyslipidemia in a Patient With Type 2 Diabetes CME/CE

Author Information and Disclosures

Release Date: September 30, 2008; Valid for credit through September 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 ANCC contact hours (0.25 contact hours are in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Solvay Pharmaceuticals
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the risk factors for cardiovascular disease in patients with diabetes
  2. Discuss the US National Cholesterol Education Program Adult Treatment Panel (NCEP/ATP) III guidelines for management of cholesterol levels in patients with diabetes with cardiovascular disease risk
  3. Evaluate treatment strategies and discuss clinical data supporting better clinical outcomes with combination therapy
  4. Discuss approaches for improving patient adherence to recommended therapy
Authors and Disclosures

Richard Nesto, MD, FACC, FAHA
Disclosure: Richard Nesto, MD, FACC, FAHA, has disclosed that he has served on the speaker's bureau for GlaxoSmithKline, Pfizer, and sanofi-aventis.


Laurie E. Scudder, MS, NP-C
Disclosure: Laurie E. Scudder, MS, NP-C, has disclosed that she has no relevant financial relationships.


Jayashree Gokhale, PhD
Disclosure: Jayashree Gokhale, PhD, has disclosed no relevant financial relationships.


David Good
Disclosure: David Good has disclosed no relevant financial relationships.


Ariana Del Negro
Disclosure: Ariana Del Negro has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

Medscape is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

 
ACPE logoMedscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Medscape is accredited by the American Council on Pharmacy Education as a provider of continuing pharmacy education. Medscape designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the American Council on Pharmacy Education (Universal Program Number 461-000-08-061-H01-P).

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.